Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,071 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $375.53 | 10 | $0 (2018) |
| Neurelis, Inc. | $125.00 | 1 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $116.11 | 6 | $0 (2024) |
| Salvin Dental Specialties, Inc. | $111.14 | 1 | $0 (2021) |
| PFIZER INC. | $89.22 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $49.12 | 3 | $0 (2024) |
| AbbVie Inc. | $43.01 | 2 | $0 (2023) |
| Grifols USA, LLC | $39.82 | 2 | $0 (2019) |
| PORTOLA PHARMACEUTICALS, INC. | $29.95 | 1 | $0 (2019) |
| HOSPIRA, INC. | $22.82 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.26 | 5 | AstraZeneca Pharmaceuticals LP ($36.51) |
| 2023 | $64.29 | 3 | Janssen Pharmaceuticals, Inc ($42.53) |
| 2022 | $71.70 | 4 | Janssen Pharmaceuticals, Inc ($37.84) |
| 2021 | $236.14 | 2 | Neurelis, Inc. ($125.00) |
| 2020 | $31.09 | 2 | Paratek Pharmaceuticals, Inc. ($17.80) |
| 2019 | $60.13 | 3 | PORTOLA PHARMACEUTICALS, INC. ($29.95) |
| 2018 | $326.72 | 8 | Allergan Inc. ($215.76) |
| 2017 | $182.59 | 5 | Allergan Inc. ($159.77) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Octapharma USA, Inc. | BALFAXAR (Biological) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: INTENSIVE CAREEMERGENCY | ||||||
| 05/17/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Rare Disease | ||||||
| 04/01/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Rare Disease | ||||||
| 01/22/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/25/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/16/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/07/2023 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/12/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: Rare Disease | ||||||
| 08/24/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/16/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/25/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/14/2021 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: EPILEPSY | ||||||
| 04/07/2021 | Salvin Dental Specialties, Inc. | — | Food and Beverage | In-kind items and services | $111.14 | General |
| 12/16/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/26/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: ANTIBIOTIC | ||||||
| 12/09/2019 | PORTOLA PHARMACEUTICALS, INC. | ANDEXXA (Biological) | Food and Beverage | Cash or cash equivalent | $29.95 | General |
| Category: HEMATOLOGY/NEUROLOGY | ||||||
| 02/13/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 01/23/2019 | Grifols USA, LLC | HyperRAB SD (Biological) | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Immunology | ||||||
| 08/31/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/02/2018 | Grifols USA, LLC | HyperRAB SD (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Immunology | ||||||
| 07/06/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/20/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $9.68 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/07/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $48.96 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/23/2018 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $128.60 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 37 | 39 | $14,880 | $5,310 |
| 2021 | 4 | 366 | 373 | $107,760 | $38,676 |
| 2020 | 4 | 269 | 273 | $80,750 | $28,708 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 26 | 28 | $9,380 | $3,379 | 36.0% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 11 | 11 | $5,500 | $1,931 | 35.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 195 | 201 | $65,100 | $23,532 | 36.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 44 | 44 | $20,975 | $7,657 | 36.5% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 103 | 104 | $20,605 | $7,328 | 35.6% |
| 93042 | Interpretation and report of electrical activity of heart using 1-3 leads | Facility | 2021 | 24 | 24 | $1,080 | $158.16 | 14.6% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 164 | 167 | $53,440 | $19,453 | 36.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 33 | 34 | $15,810 | $5,656 | 35.8% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 59 | 59 | $10,915 | $3,512 | 32.2% |
| 93042 | Interpretation and report of electrical activity of heart using 1-3 leads | Facility | 2020 | 13 | 13 | $585.00 | $87.72 | 15.0% |
About Dr. Lawrence Schiff, MD
Dr. Lawrence Schiff, MD is a Emergency Medicine healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326075185.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Schiff, MD has received a total of $1,071 in payments from pharmaceutical and medical device companies, with $98.26 received in 2024. These payments were reported across 32 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,071).
As a Medicare-enrolled provider, Schiff has provided services to 672 Medicare beneficiaries, totaling 685 services with total Medicare billing of $72,694. Data is available for 3 years (2020–2022), covering 10 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Stony Brook, NY
- Active Since 06/27/2006
- Last Updated 11/20/2018
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1326075185
Products in Payments
- DALVANCE (Drug) $347.82
- VALTOCO (Drug) $125.00
- XARELTO (Drug) $116.11
- ELIQUIS (Drug) $89.22
- ANDEXXA (Biological) $79.07
- AVYCAZ (Drug) $48.96
- HyperRAB SD (Biological) $39.82
- THROMBIN (Drug) $22.82
- DIFICID (Drug) $22.02
- TEFLARO (Drug) $21.76
- NUZYRA (Drug) $17.80
- BALFAXAR (Biological) $17.28
- NUEDEXTA (Drug) $12.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Stony Brook
Dr. Adam Singer, M.d, M.D
Emergency Medicine — Payments: $675,767
Paul Taglienti, Md, MD
Emergency Medicine — Payments: $1,924
Dr. Jose Torres, Md, MD
Emergency Medicine — Payments: $1,565
Dr. Joseph Corcoran, Md, MD
Emergency Medicine — Payments: $813.09
Dr. Sayed Khwaja, D.o, D.O
Emergency Medicine — Payments: $612.51
Dr. Jerome Wilkerson, M.d, M.D
Emergency Medicine — Payments: $499.23